Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

CORTCORT

Showing 8 of 28 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in CORCEPT THERAPEUTICS INC

Yes. Bank of New York Mellon holds 565,666 shares of CORT (Corcept Therapeutics), worth $49.2M, as of its Q2 2026 13F filing. It increased the position by 21,909 shares (+4.0%) from Q1 2026. Bank of New York Mellon has held CORT in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$49.2M

Current Shares

565,666

Total Value Change

+$21.2M

Total Shares Change

-39,742

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
565,666
+4.0%
$49.2M0.0%$86.95
30
2026-Q1
Decreased
543,757
-6.5%
$21.9M0.0%$40.31
0
2025-Q4
Decreased
581,656
-3.3%
$20.2M0.0%$34.80
0
2025-Q3
Decreased
601,499
-5.8%
$50M0.0%$83.11
0
2025-Q2
Increased
638,722
+9.5%
$46.9M0.0%$73.40
32
2025-Q1
Decreased
583,093
-1.1%
$66.6M0.0%$114.22
0
2024-Q4
Decreased
589,771
-2.6%
$29.7M0.0%$50.39
0
2024-Q3
Decreased
605,408
-10.7%
$28M0.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used